(Updates with stock price movement in the headline and second paragraph)
Novo Nordisk A/S (NVO) and Hims & Hers Health (HIMS) partnered to enable US consumers to access NovoCare pharmacy directly through the Hims platform with a bundled offering of all dose strengths of Wegovy and a Hims membership for $599 a month, the companies said Tuesday.
Hims shares jumped 26% in recent Tuesday trading, and Novo Nordisk rose 3.6%.
Price: 64.89, Change: +2.27, Percent Change: +3.63
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。